There are 10,000 known diseases in the world. Somehow, even today, treatment only exists for 500 of those. That is a staggering number, but the House of Representatives and the Senate have been working together to give our healthcare industries the tools to fix it.
Last week, I helped pass the 21st Century Cures Act, a bill that streamlines the review of life-saving drugs, provides funding to continue researching cures for rare and deadly diseases, and accelerates critical therapies for at-risk patients across the country.
Specifically, by increasing the speed at which cutting edge or experimental drugs are approved by the Federal Drug Administration (FDA), the 21st Century Cures Act breaks down the barriers that have prevented millions of Americans from getting the drug and disease treatments their lives depend on.
This means the FDA maintains responsible safety procedures but can avoid so many of the obstacles they face before getting drugs to patients. The bill also seeks to improve the FDA’s decision-making process by bringing in patients to share their experiences and help shape the agency’s policies going forward.
All new funding in the 21st Century Cures Act will be fully offset with cuts to previously approved spending. Additionally, all programs will be reviewed annually in order to ensure taxpayers are getting the best and most efficient return possible on this investment.
Thousands of the diseases that are currently “incurable” don’t have to stay that way. We have a unique opportunity to bring our healthcare system into the 21st century, and spur cutting-edge medicines and treatments that can save lives. This bill will allow us to do just that.